Key Highlights

  • Shipments for the September quarter were 46.8 million tonnes, down 6 per cent on the prior year.
  • Sales have been held back by unresolved negotiations with China Mineral Resources Group.
  • Full-year guidance for shipments, unit costs and Capital Expenditure is unchanged.
  • Operations could be affected if no resolution is reached by the end of the calendar year.

Fortescue Ltd (ASX:FMG), a constituent of the S&P/ASX 200 Materials index, is facing a more uncertain sales environment than its record full-year shipments might suggest. Its September quarter update, released on 22 October 2026, showed sales held back by unresolved negotiations with China Mineral Resources Group (CMRG).

The answer, on the evidence so far, is that the dispute matters considerably for near-term volumes, but the company has left its full-year guidance unchanged and the outcome remains unknown.

What the company does

Fortescue is a Western Australian iron ore producer operating mines, rail and port infrastructure in the Pilbara. Its main product is hematite ore, supplemented by Iron Bridge, a magnetite project that produces higher-grade concentrate. It also invests in renewable energy and copper. Most of its ore is sold to Chinese steelmakers.

Latest developments

For the quarter ended 30 September 2026, Fortescue reported shipments of 46.8 million tonnes, down 6 per cent on the prior year and including 2.5 million tonnes from Iron Bridge. Sales were lower, at 42.9 million tonnes, which the company attributed to the ongoing CMRG negotiations.

Management said guidance for shipments, unit costs and capital expenditure is unchanged, but also cautioned that operations could be affected if no resolution is reached by the end of the calendar year.

Operationally, the Green Metal Project at Christmas Creek produced its first hot metal, and Blacksmith reported its first Ore Reserve of 196 million tonnes.

Financial and operational evidence

In the September quarter, hematite C1 unit cost was US$21.98 per wet tonne, against US$18.17 a year earlier. Hematite realised price was US$79.79 per dry tonne, or 82 per cent of the Platts 61 per cent index. Cash at 30 September 2026 was US$3.2 billion and net Debt was US$2.8 billion, after the final Dividend and capital spending.

The full-year result, published on 20 August 2026, was stronger. For the year to 30 June 2026 Fortescue reported Revenue of US$17.0 billion, underlying EBITDA of US$8.6 billion at a 51 per cent margin, underlying net profit after tax of US$3.5 billion and free Cash Flow of US$3.2 billion. Record shipments of 201.3 million tonnes were achieved at a hematite C1 cost of US$18.74 per wet tonne. Net debt was US$0.9 billion, and a fully Franked Dividend of A$1.08 per share was declared. Future dividends are not assured.

FY27 guidance, set in August, calls for shipments of 197 to 207 million tonnes, a hematite C1 cost of US$20.50 to US$21.75 per wet tonne and metals capital expenditure of up to US$4.7 billion.

Material risks

The price discount to the benchmark index, at 82 per cent for hematite, also leaves Earnings sensitive to ore quality and market conditions. Iron ore prices and Chinese steel Demand remain outside management's control. Unit costs are rising, and the September quarter figure sits just above the top of the full-year guidance range. Net debt has risen since June, while heavy capital commitments add funding risk.

Milestones to watch

Investors will likely follow whether Fortescue and CMRG reach agreement before the end of the 2026 calendar year, and how inventory and sales volumes evolve in the December quarter report. Other markers include progress on unit costs against guidance and and the next half-year result, for updated earnings, cost trends, capital allocation detail and any change to guidance, alongside the December quarter report.